Discover 1,423 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,423
Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry
for
Coronary Artery Disease
Location: Cleveland OH, Charlottesville VA, Minneapolis MN
Sponsor: BSP Biological Signal Processing Ltd.
Sex: All
Age: 18+
Code: NCT01325467
Recruiting
Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction
Location: Cleveland OH, San Antonio TX, San Francisco CA
Sponsor: Epibone, Inc.
Sex: All
Age: 18 - 65
Code: NCT03678467
Phase1, Phase2, Recruiting
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
for
Atrial Fibrillation, Obesity
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18 - 70+
Code: NCT06802081
Phase2, Recruiting
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
for
Giant Cell Tumor of Bone
Location: Cleveland OH, Pittsburgh PA, Indianapolis IN,
Sponsor: St. Louis University
Sex: All
Age: 18+
Code: NCT03295981
Phase3, Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: Cleveland OH, Troy MI, Springfield OH, Midland MI,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06585410
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
for
Nausea, Vomiting
Location: Cleveland OH, Indianapolis IN, Louisville KY,
Sponsor: Enterra Medical, Inc.
Sex: All
Age: 18+
Code: NCT06464926
Recruiting
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
for
PSMA PET-Positive Castration-Resistant Prostate Cancer
Location: Cleveland OH, Durham NC, New York NY, St Louis MO,
Sponsor: Convergent Therapeutics
Sex: Male
Age: 18+
Code: NCT06549465
Phase2, Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Cleveland OH, Detroit MI, London, Oakville, Richmond IN,